Healthcare

Premium

Healthcare

16 May, 2024

Exclusive: Poonawalla's Serum Institute forays into medtech via acquisition

Serum Institute of India (SII), the world's biggest vaccine maker, has picked up a minority stake in a medical technology company, two ......

Premium

Healthcare

15 May, 2024

Bottomline: How PlasmaGen Bio plans to break its streak of revenue stagnancy

Bengaluru-based biopharmaceutical company PlasmaGen Biosciences Pvt. Ltd, backed by venture capital firm Eight Roads Ventures, is poised to break out ......

Healthcare

15 May, 2024

Jungle Ventures leads $20 mn Series B round in RED.Health

Medical emergency response platform RED.Health, which claims to dispatch ambulances within eight minutes, has raised $20 million (Rs 167 crore) ......

Premium

Healthcare

14 May, 2024

Mahindra's PE arm exits healthcare firm as new investor comes on board

Mahindra Partners, the private equity arm of diversified Mahindra Group, has made a complete exit from a five-year-old healthcare bet ......

Premium

Healthcare

14 May, 2024

Biorad brings new PE investor on board after giving exit to InvAscent

Medical devices maker Biorad Medisys Pvt Ltd, which was backed by healthcare-focused private equity firm InvAscent, is set to welcome a new private ......

Premium

Healthcare

10 May, 2024

Spotlight: Ascent-backed Skanray needs to defy one-trick-pony act to get new investors

Mysore-based medical device manufacturer Skanray Technologies Pvt. Ltd recorded robust growth during FY21 amid a raging pandemic but has since ......

Pro

Healthcare

09 May, 2024

ChrysCap makes a liquidity move with benchmark returns

Indian private equity firm ChrysCapital, which was recently trumped by Kedaara Capital in raising the largest India-focused fund of its kind, has ......

Pro

Healthcare

09 May, 2024

How did Investcorp's latest India exit move pan out?

Bahrain-based alternative asset manager Investcorp has made its second India exit move of 2024, adding to its harvests last year ......

Premium

Healthcare

09 May, 2024

Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal

Kelix Bio, an emerging markets-focused specialty generic biopharmaceutical company is looking to acquire five UAE-based pharma entities to further expand ......

Premium

Healthcare

08 May, 2024

Warburg, Carlyle, others in fray for stake in healthcare tech solutions provider

A string of global buyout firms including Thoma Bravo, CVC Capital, Carlyle, Platinum Equity and Warburg Pincus are evaluating an ......